224 related articles for article (PubMed ID: 25377471)
21. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.
Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075
[TBL] [Abstract][Full Text] [Related]
22. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
24. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
Rosanò L; Bagnato A
J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
[TBL] [Abstract][Full Text] [Related]
25. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
29. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
30. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
[TBL] [Abstract][Full Text] [Related]
31. G protein- and
Xiong X; Nazo N; Revoori R; Rajagopal S; Sparks MA
Kidney360; 2021 Jul; 2(7):1124-1131. PubMed ID: 35368349
[TBL] [Abstract][Full Text] [Related]
32. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
[TBL] [Abstract][Full Text] [Related]
33. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
[TBL] [Abstract][Full Text] [Related]
34. Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.
Sestito R; Cianfrocca R; Tocci P; Rosanò L; Sacconi A; Blandino G; Bagnato A
Commun Biol; 2020 Nov; 3(1):677. PubMed ID: 33188287
[TBL] [Abstract][Full Text] [Related]
35. Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach.
Tocci P; Rosanò L; Bagnato A
Front Endocrinol (Lausanne); 2019; 10():609. PubMed ID: 31551935
[TBL] [Abstract][Full Text] [Related]
36. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
Chen J; Hu Q; Zhou C; Jin D
Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
[TBL] [Abstract][Full Text] [Related]
37. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
[TBL] [Abstract][Full Text] [Related]
38. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].
Zhang YL; Xia XK; Zhang M
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):930-938. PubMed ID: 38123199
[No Abstract] [Full Text] [Related]
39. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
Burkhalter RJ; Westfall SD; Liu Y; Stack MS
J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
[TBL] [Abstract][Full Text] [Related]
40. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]